ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Amgen's Repatha hits wall at SCOTUS but presses ahead—new price breaks included
January 13, 2019Amgen has been trying since 2015 to protect its PCSK9 cholesterol drug Repatha by keeping Sanofi and Regeneron’s rival Praluent off the market, even going as far as to ask the U.S. Supreme Court to review an ongoing patent fight. -
Amgen's Repatha hits wall at SCOTUS but presses ahead—new price breaks included
January 13, 2019Amgen has been trying since 2015 to protect its PCSK9 cholesterol drug Repatha by keeping Sanofi and Regeneron’s rival Praluent off the market, even going as far as to ask the U.S. Supreme Court to review an ongoing patent fight.
Pharma Sources Insight January 2025
